Roosevelt Investment Group’s AstraZeneca AZN Stock Holding History

Roosevelt Investment Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.95M	Buy	36,000 +93	+0.3%	+$11.8K	0.28%	62
2022 Q2	$4.75M	Buy	35,907 +907	+3%	+$119K	0.34%	57
2022 Q1	$4.64M	Hold	35,000	–	–	0.28%	60
2021 Q4	$4.08M	Buy	35,000 +5,000	+17%	+$588K	0.23%	65
2021 Q3	$3.6M	Hold	30,000	–	–	0.22%	63
2021 Q2	$3.59M	Hold	30,000	–	–	0.22%	63
2021 Q1	$2.98M	Sell	30,000 -586	-2%	-$58.9K	0.2%	69
2020 Q4	$3.06M	Buy	30,586 +305	+1%	+$32.3K	0.22%	61
2020 Q3	$3.32M	Buy	+30,281	New	+$3.37M	0.27%	59

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Roosevelt Investment Group's AZN Position: Q3 2022 in Review

Roosevelt Investment Group increased its AstraZeneca (AZN) stake by 0.26% in Q3 2022, buying an estimated $11.8K and bringing the position to 36,000 shares worth $3.95M. The position accounts for 0.28% of the portfolio, ranked #62.

Roosevelt Investment Group first reported a position in AZN in Q3 2020 and has held it in 9 quarters since. The position peaked at $4.75M in Q2 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Roosevelt Investment Group held 36,000 shares of AstraZeneca worth $3.95M as of Q3 2022.
Roosevelt Investment Group bought 93 AstraZeneca shares in Q3 2022, an estimated $11.8K.
AstraZeneca made up 0.28% of Roosevelt Investment Group's portfolio in Q3 2022, its #62 holding.
Roosevelt Investment Group first reported a position in AstraZeneca in Q3 2020 and has held it in 9 quarters since.
Roosevelt Investment Group's AstraZeneca position peaked at $4.75M in Q2 2022.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.